![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 2055-2335|37|2|93-93
ISSN: 1445-937x
Source: JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.37, Iss.2, 2007-06, pp. : 93-93
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemcitabine plus cisplatin for NSCLC
Inpharma, Vol. 1, Iss. 1222, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemcitabine plus vinorelbine superior in NSCLC
Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thyroxine plus liothyronine: no QOL benefit
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 439, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Delayed-Release Lansoprazole plus Naproxen
By Curran Monique P. Wellington Keri
Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oxaliplatin plus paclitaxel in advanced NSCLC
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :